Flen Health

Flen Health is a commercial-stage, privately-held medical device company focused on advanced wound and skin care. With a core biotechnological approach, its product portfolio, including Flaminal and Flamigel, addresses a range of conditions from chronic wounds to radiotherapy-induced skin damage. The company has established a direct commercial presence in multiple European countries and employs over 110 people, leveraging over two decades of experience to serve healthcare professionals and patients.

Biotechnological approach to wound management using formulated hydrogels and enzyme-alginate systems to create an optimal wound healing environment.

Operates in the crowded advanced wound care market, competing against giants like Smith & Nephew, Mölnlycke, and ConvaTec, as well as other specialty dermatology companies. Differentiates through a focused biotech-inspired approach and niche products for radiotherapy skin reactions and chronic itch.